Over the last two decades tremendous efforts have been made to develop new pharmacological therapies to treat MS. Unfortunately, these medications result in significant toxic side effects that severely damage the patient’s quality of life. 

​

Because BI’s approach to autoimmune diseases is non-pharmacological, it is not trigger toxic side effects. BI’s unique filtration procedure is based on the principles of precision medicine; it will be used only 2-3 times per year on average, and can replace the current pharmacological treatments.